Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases
- PMID: 36483677
- PMCID: PMC9723159
- DOI: 10.3389/fcell.2022.1070208
Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases
Abstract
Hepatic macrophages have been recognized as primary sensors and responders in liver inflammation. By processing host or exogenous biochemical signals, including microbial components and metabolites, through the gut-liver axis, hepatic macrophages can both trigger or regulate inflammatory responses. Crosstalk between hepatic macrophages and gut microbiota is an important component of liver inflammation and related liver diseases, such as acute liver injury (ALI), alcoholic liver disease (ALD), and nonalcoholic fatty liver disease (NAFLD). This review summarizes recent advances in knowledge related to the crosstalk between hepatic macrophages and gut microbiota, including the therapeutic potential of targeting hepatic macrophages as a component of gut microecology in inflammation-associated liver diseases.
Keywords: gut microbiota; gut-liver axis; inflammation; innate immunity; liver disease; macrophage.
Copyright © 2022 Zhou, Pan and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Host-Microbiota Interactions in Liver Inflammation and Cancer.Cancers (Basel). 2021 Aug 27;13(17):4342. doi: 10.3390/cancers13174342. Cancers (Basel). 2021. PMID: 34503151 Free PMC article. Review.
-
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.Int J Mol Sci. 2021 Dec 31;23(1):426. doi: 10.3390/ijms23010426. Int J Mol Sci. 2021. PMID: 35008852 Free PMC article. Review.
-
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.Front Med (Lausanne). 2022 Jul 22;9:913842. doi: 10.3389/fmed.2022.913842. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35935787 Free PMC article. Review.
-
Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology.Chin Med. 2021 Jul 27;16(1):62. doi: 10.1186/s13020-021-00470-x. Chin Med. 2021. PMID: 34315516 Free PMC article. Review.
-
Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding.Food Funct. 2022 Jan 24;13(2):596-608. doi: 10.1039/d1fo02892h. Food Funct. 2022. PMID: 34927188
Cited by
-
LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel). 2025 Mar 23;18(4):451. doi: 10.3390/ph18040451. Pharmaceuticals (Basel). 2025. PMID: 40283890 Free PMC article.
-
Mitochondrial Metabolism in X-Irradiated Cells Undergoing Irreversible Cell-Cycle Arrest.Int J Mol Sci. 2023 Jan 17;24(3):1833. doi: 10.3390/ijms24031833. Int J Mol Sci. 2023. PMID: 36768155 Free PMC article.
-
The potential roles of gut microbiome in porto-sinusoidal vascular disease: an under-researched crossroad.Front Microbiol. 2025 Mar 3;16:1556667. doi: 10.3389/fmicb.2025.1556667. eCollection 2025. Front Microbiol. 2025. PMID: 40099185 Free PMC article. Review.
-
Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease.Cells. 2025 Jan 30;14(3):207. doi: 10.3390/cells14030207. Cells. 2025. PMID: 39936998 Free PMC article. Review.
References
-
- Bao T., He F., Zhang X., Zhu L., Wang Z., Lu H., et al. (2020). Inulin exerts beneficial effects on non-alcoholic fatty liver disease via modulating gut microbiome and suppressing the lipopolysaccharide-toll-like receptor 4-mψ-nuclear factor-κb-nod-like receptor protein 3 pathway via gut-liver Axis in mice. Front. Pharmacol. 11, 558525. 10.3389/fphar.2020.558525 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources